Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)
CAPS Rating:
A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.
RSS Headlines
Fool UK
Recs
more downside to come